上颌下颌前徙术治疗阻塞性睡眠呼吸暂停的安全性与有效性:系统评价与Meta分析
该系统评价与Meta分析纳入31项研究共1597例患者,评估上颌下颌前徙术治疗阻塞性睡眠呼吸暂停的有效性与后遗症。术后呼吸暂停低通气指数、呼吸紊乱指数、最低血氧饱和度、Epworth嗜睡量表评分及体重指数均显著改善,最常见后遗症为下面部麻木和硬件取出,无重大并发症或死亡报告。
要点
- 上颌下颌前徙术后呼吸暂停低通气指数平均降低41.87次/小时(95%CI -49.86至-33.89)。
- 早期下面部麻木发生率83.40%,随访不足1年及超过1年分别为66.51%和32.73%。
- 硬件取出发生率21.99%,未报告重大并发症或死亡。
主要发现
- 呼吸暂停低通气指数平均降低41.87次/小时(95%CI -49.86至-33.89)。
- 呼吸紊乱指数平均降低46.24次/小时(95%CI -62.18至-30.29)。
- 最低血氧饱和度平均升高6.29%(95%CI 3.42至12.08)。
- Epworth嗜睡量表评分平均降低8.69(95%CI -11.54至-5.83)。
- 体重指数平均降低0.74 kg/m2(95%CI -1.35至-0.12)。
关键数值与推荐
- 早期下面部麻木发生率83.40%。
- 随访不足1年下面部麻木发生率66.51%,随访超过1年发生率32.73%。
- 硬件取出发生率21.99%。
- 术前体重指数与住院时长正相关(r=0.81,P=.052),年龄与下面部麻木正相关(r=0.42,P=.196),呼吸暂停低通气指数变化与随访时间负相关(r=0.75,P=.087)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide an updated evaluation of clinical effectiveness and sequelae of maxillomandibular advancement surgery in obstructive sleep apnea. DATA SOURCES: PubMed, Scopus, CINAHL. REVIEW METHODS: Included studies described patients with obstructive sleep apnea that completed maxillomandibular advancement with any reported sequelae. Meta-analysis of proportions, regressions, and single means with 95% confidence interval were calculated using random and fixed effects models. RESULTS: Of 380 unique abstracts reviewed, a total of 31 studies (n = 1597) were included in meta-analysis. Maxillomandibular advancement patients showed significant improvements in apnea-hypopnea index (AHI), respiratory disturbance index (RDI), SpO2 Nadir, Epworth sleepiness scale (ESS), and body-mass index (BMI) by -41.87/h [-49.86 to -33.89], -46.24/h [-62.18 to -30.29], 6.29% [3.42 to 12.08], -8.69 [-11.54 to -5.83], and -0.74 kg/m2 [-1.35 to -0.12], respectively. Sequelae with the greatest incidence were early lower facial numbness (83.40%), late lower facial numbness at less and greater than 1 year follow-up (66.51%, 32.73% respectively), and hardware removal (21.99%). There was a positive correlation between both preoperative BMI and length of hospital stay (r = 0.81, P = .052) and age and lower facial numbness (r = 0.42, P = .196). A negative correlation was found between Change in AHI and time to follow up (r = 0.75, P = .087). No major complications nor mortality were reported. CONCLUSION: Maxillomandibular advancement has the highest success rate for obstructive sleep apnea among current surgical treatments, with most sequelae being transient. Early lower facial numbness should be highlighted preoperatively to ensure informed decision-making. Further research should be geared towards reducing this risk.
引用
- Walker A, Kassir MF, Sama V, et al. Maxillomandibular Advancement Safety and Effectiveness in Obstructive Sleep Apnea: Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2025. PMID: 39764681. doi:10.1002/ohn.1114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。